Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Soluble CD95 Ligand Role in the Pathophysiology of ANCA Associated Vasculitis
NCT03698071Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Dec 2018
- Primary completion
- Sep 2024
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Change of quantitative levels of s-CD95-L at 12 months. Started Dec 2018; status: completed.
Beyond the preview
Go deeper on NCT03698071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03698071.